$145.82
| Strength | 36 I.U |
| Brand | Pfizer |
| Packaging Type | Pen |
| Usage/Application | Clinical |
| Packaging Size | 12mg/ml |
| Injectable Form | Lyophilized Powder |
| Manufacturer | Pfizer |
| Usage | To treat Growth Hormone Deficiency (GHD) |
| Prescription/Non-Prescription | Prescription |
| Country of Origin | Made in India |
| Availability | In Stock |
Recombinant 12 mg (36IU) ALLEY is a formulation of Somatropin, a laboratory-produced version of human growth hormone (HGH). It is used in clinical medicine to manage conditions associated with growth hormone deficiency and impaired growth. This medication is prescription-only and should be used under qualified medical supervision.
Recombinant human growth hormone (rHGH) is designed to replicate the natural hormone produced by the pituitary gland. It plays a key role in:
When natural HGH levels are insufficient, somatropin therapy may be prescribed.
Somatropin-based therapies such as Recombinant 12 mg (36IU) ALLEY are prescribed for:
Use outside approved medical indications should only occur under medical supervision.
Somatropin mimics the effects of natural growth hormone by:
This helps restore normal physiological function in individuals with hormone deficiencies.
Patients should strictly follow prescribed instructions.
Seek immediate medical attention if severe or persistent symptoms occur.
Due to the risk of counterfeit hormone products:
Somatropin products, including Recombinant 12 mg (36IU) ALLEY, are regulated medications in most countries. Unauthorized use or distribution may be subject to legal restrictions.

















